Merck
CN
所有图片(1)

文件

549835

Sigma-Aldrich

2,4,6-三(二甲氨基)均三嗪

96%

登录查看公司和协议定价
所有图片(1)
别名:
六甲三聚氰胺, 六甲蜜胺
经验公式（希尔记法）:
C9H18N6
CAS号:
645-05-6
分子量:
210.28
EC 号:
211-428-4
MDL编号:
MFCD00549245
PubChem化学物质编号:
24874728
NACRES:
NA.22

质量水平

100

检测方案

96%

mp

171-175 °C (lit.)

SMILES string

CN(C)c1nc(nc(n1)N(C)C)N(C)C

InChI

1S/C9H18N6/c1-13(2)7-10-8(14(3)4)12-9(11-7)15(5)6/h1-6H3

InChI key

UUVWYPNAQBNQJQ-UHFFFAOYSA-N

正在寻找类似产品? Visit 产品对比指南

相关类别

一般描述

2,4,6-Tris(dimethylamino)-1,3,5-triazine exhibits antitumor activity.

象形图

Exclamation mark
GHS07

警示用语：

Warning

危险分类

Acute Tox. 4 Oral - Eye Irrit. 2 - Skin Irrit. 2 - STOT SE 3

靶器官

Respiratory system

储存分类代码

11 - Combustible Solids

WGK

WGK 3

闪点(°F)

Not applicable

闪点(°C)

Not applicable

个人防护装备

dust mask type N95 (US), Eyeshields, Faceshields, Gloves

分析证书(COA)

输入产品批号来搜索 分析证书(COA) 。批号可以在产品标签上"批“ （Lot或Batch）字后找到。

已有该产品？

为方便起见，与您过往购买产品相关的文件已保存在文档库中。

访问文档库

难以找到您所需的产品或批次号码？

在网站页面上，产品编号会附带包装尺寸/数量一起显示（例如：T1503-25G）。请确保 在“产品编号”字段中仅输入产品编号 (示例: T1503).

示例

T1503
货号
-
25G
包装规格/数量

其它示例：

705578-5MG-PW

PL860-CGA/SHF-1EA

MMYOMAG-74K-13

1000309185

输入内容 1.000309185)

遇到问题？欢迎随时联系我们技术服务 寻求帮助

批号可以在产品标签上"批“ （Lot或Batch）字后面找到。

Aldrich 产品

  • 如果您查询到的批号为 TO09019TO 等，请输入去除前两位字母的批号：09019TO。

  • 如果您查询到的批号含有填充代码（例如05427ES-021），请输入去除填充代码-021的批号：05427ES。

  • 如果您查询到的批号含有填充代码（例如 STBB0728K9），请输入去除填充代码K9的批号：STBB0728。

未找到您寻找的产品？

部分情况下，可能未在线提供COA。如果搜索不到COA，可在线索取。

索取COA

Triazines and related products. Part 26. Synthesis and chemistry of bicyclic analogues of the antitumour drug 2, 4, 6-tris (dimethylamino)-1, 3, 5-triazine (hexamethylmelamine).
Langdon SP, et al.
Journal of the Chemical Society. Perkin Transactions 1, 993-998 (1984)
Rafael Samper-Ternent et al.
Journal of the American Geriatrics Society, 56(10), 1845-1852 (2008-09-25)
To examine the association between frailty status and change in cognitive function over time in older Mexican Americans. Data used were from the Hispanic Established Population for the Epidemiological Study of the Elderly. Five southwestern states: Texas, New Mexico, Colorado
I Olver et al.
Cancer chemotherapy and pharmacology, 48(2), 109-114 (2001-09-20)
The efficacy and pharmacokinetics of paclitaxel when combined with altretamine for ovarian cancer were studied. A group of 30 patients, whose only chemotherapy was one or more cisplatin-based non-paclitaxel-containing regimens and whose ovarian cancer failed to respond or had relapsed
Better treatments improve survival of CHD patients.
Loretta Ninivaggi
The Nurse practitioner, 30(9), 57-63 (2005-09-10)
Thomas J Herzog
Clinical cancer research : an official journal of the American Association for Cancer Research, 10(22), 7439-7449 (2004-12-01)
Ovarian cancer is increasingly recognized as a chronic disease whose treatment is often characterized by administration of multiple, sequential active agents, each of which may or may not be accompanied by a tumor response. Despite the large proportion of patients
查看所有相关文献

我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门